Once it was found that the levels of Gal-9 mRNA and protein are increased in AD and after treatment with dupilumab they are reduced, our next step was to evaluate the effect of exogenous administration of Gal-9 on keratinocytes under different cytokine stimulation. The gene discussed is LGALS9; the disease is Alzheimer disease.